These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16260726)

  • 1. Detection of functional single-nucleotide polymorphisms that affect apoptosis.
    Harris SL; Gil G; Robins H; Hu W; Hirshfield K; Bond E; Bond G; Levine AJ
    Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16297-302. PubMed ID: 16260726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-nucleotide polymorphisms in the p53 pathway.
    Harris SL; Gil G; Hu W; Robins H; Bond E; Hirshfield K; Feng Z; Yu X; Teresky AK; Bond G; Levine AJ
    Cold Spring Harb Symp Quant Biol; 2005; 70():111-9. PubMed ID: 16869744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined effects of genetic variants of the PTEN, AKT1, MDM2 and p53 genes on the risk of nasopharyngeal carcinoma.
    Zhang X; Chen X; Zhai Y; Cui Y; Cao P; Zhang H; Wu Z; Li P; Yu L; Xia X; He F; Zhou G
    PLoS One; 2014; 9(3):e92135. PubMed ID: 24632578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDM2-dependent inhibition of p53 is required for Epstein-Barr virus B-cell growth transformation and infected-cell survival.
    Forte E; Luftig MA
    J Virol; 2009 Mar; 83(6):2491-9. PubMed ID: 19144715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PI3K/AKT and Mdm2 activation are associated with inhibitory effect of cAMP increasing agents on DNA damage-induced cell death in human pre-B NALM-6 cells.
    Ghorbani A; Jeddi-Tehrani M; Saidpour A; Safa M; Bayat AA; Zand H
    Arch Biochem Biophys; 2015 Jan; 566():58-66. PubMed ID: 25524737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of p53 protein by gamma radiation in lymphocyte lines from breast cancer and ataxia telangiectasia patients.
    Birrell GW; Ramsay JR
    Br J Cancer; 1995 Nov; 72(5):1096-101. PubMed ID: 7577453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDM2 T309G has a synergistic effect with P21 ser31arg single nucleotide polymorphisms on the risk of acute myeloid leukemia.
    Ebid GT; Sedhom IA; El-Gammal MM; Moneer MM
    Asian Pac J Cancer Prev; 2012; 13(9):4315-20. PubMed ID: 23167335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Onzin, a c-Myc-repressed target, promotes survival and transformation by modulating the Akt-Mdm2-p53 pathway.
    Rogulski K; Li Y; Rothermund K; Pu L; Watkins S; Yi F; Prochownik EV
    Oncogene; 2005 Nov; 24(51):7524-41. PubMed ID: 16170375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ret finger protein 2 enhances ionizing radiation-induced apoptosis via degradation of AKT and MDM2.
    Joo HM; Kim JY; Jeong JB; Seong KM; Nam SY; Yang KH; Kim CS; Kim HS; Jeong M; An S; Jin YW
    Eur J Cell Biol; 2011 May; 90(5):420-31. PubMed ID: 21333377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mdm2 phosphorylation by Akt regulates the p53 response to oxidative stress to promote cell proliferation and tumorigenesis.
    Chibaya L; Karim B; Zhang H; Jones SN
    Proc Natl Acad Sci U S A; 2021 Jan; 118(4):. PubMed ID: 33468664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. hTERT inhibition triggers Epstein-Barr virus lytic cycle and apoptosis in immortalized and transformed B cells: a basis for new therapies.
    Giunco S; Dolcetti R; Keppel S; Celeghin A; Indraccolo S; Dal Col J; Mastorci K; De Rossi A
    Clin Cancer Res; 2013 Apr; 19(8):2036-47. PubMed ID: 23444223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 Signaling Pathway Polymorphisms Associated With Emphysematous Changes in Patients With COPD.
    Mizuno S; Ishizaki T; Kadowaki M; Akai M; Shiozaki K; Iguchi M; Oikawa T; Nakagawa K; Osanai K; Toga H; Gomez-Arroyo J; Kraskauskas D; Cool CD; Bogaard HJ; Voelkel NF
    Chest; 2017 Jul; 152(1):58-69. PubMed ID: 28315337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human lymphoblastoid cell lines expressing mutant p53 exhibit decreased sensitivity to cisplatin-induced cytotoxicity.
    Piovesan B; Pennell N; Berinstein NL
    Oncogene; 1998 Nov; 17(18):2339-50. PubMed ID: 9811465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of functional DNA variants in the constitutive promoter region of MDM2.
    Lalonde ME; Ouimet M; Larivière M; Kritikou EA; Sinnett D
    Hum Genomics; 2012 Sep; 6(1):15. PubMed ID: 23244604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteins and single nucleotide polymorphisms involved in apoptosis, growth control, and DNA repair predict cisplatin sensitivity in head and neck cancer cell lines.
    Farnebo L; Jedlinski A; Ansell A; Vainikka L; Thunell LK; Grénman R; Johansson AC; Roberg K
    Int J Mol Med; 2009 Oct; 24(4):549-56. PubMed ID: 19724896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-nucleotide polymorphisms in the p53 signaling pathway.
    Grochola LF; Zeron-Medina J; Mériaux S; Bond GL
    Cold Spring Harb Perspect Biol; 2010 May; 2(5):a001032. PubMed ID: 20452958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the ATPase domain of the Cockayne syndrome group B protein in UV induced apoptosis.
    Balajee AS; Proietti De Santis L; Brosh RM; Selzer R; Bohr VA
    Oncogene; 2000 Jan; 19(4):477-89. PubMed ID: 10698517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus-encoded EBNA-5 forms trimolecular protein complexes with MDM2 and p53 and inhibits the transactivating function of p53.
    Kashuba E; Yurchenko M; Yenamandra SP; Snopok B; Szekely L; Bercovich B; Ciechanover A; Klein G
    Int J Cancer; 2011 Feb; 128(4):817-25. PubMed ID: 20473904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms of p53 and MDM2 genes are associated with severe toxicities in patients with non-small cell lung cancer.
    Zheng D; Chen Y; Gao C; Wei Y; Cao G; Lu N; Hou Y; Jiang X; Wang J
    Cancer Biol Ther; 2014; 15(11):1542-51. PubMed ID: 25482940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The importance of a SNiP of the MDM2 gene to modulate the p53 pathway and the predisposition to cancer].
    Larsen CJ
    Bull Cancer; 2011 Jan; 98(1):10. PubMed ID: 21591298
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.